BIO RAD LABORATORIES INC | 2013 | FY | 3

The impact of the immaterial error correction, and the reclassification, both described above on our Consolidated Balance Sheet and Consolidated Statements of Income for the periods presented is as follows (in thousands, except per share data):

 
 
December 31, 2012
 
 
As reported
 
Adjustment
 
As revised
Inventories: finished goods
 
$
230,624

 
$
6,750

 
$
237,374

Total inventories
 
448,370

 
6,750

 
455,120

Total current assets
 
1,929,932

 
6,750

 
1,936,682

Total assets
 
3,436,753

 
6,750

 
3,443,503

Income and other taxes payable
 
32,299

 
2,480

 
34,779

Total current liabilities
 
469,920

 
2,480

 
472,400

Total liabilities
 
1,425,483

 
2,480

 
1,427,963

Total stockholders' equity
 
2,011,270

 
4,270

 
2,015,540

Total liabilities and stockholders' equity
 
$
3,436,753

 
$
6,750

 
$
3,443,503


 
Year ended December 31,
 
2012
 
2011
 
As reported
Adjustment
As revised
 
As reported
Adjustment
As revised
Cost of goods sold
$
915,097

$
(1,020
)
$
914,077

 
$
895,640

$
(940
)
$
894,700

Gross profit
1,154,138

1,020

1,155,158

 
1,177,889

940

1,178,829

Selling, general and administrative expense
682,898

(1,120
)
681,778

 
696,294

(310
)
695,984

Research and development expense
214,040

(4,836
)
209,204

 
186,439

(8,835
)
177,604

Income from operations
257,200

6,976

264,176

 
295,156

10,085

305,241

Income before income taxes
222,931

6,976

229,907

 
235,762

10,085

245,847

Provision for income taxes
59,084

5,277

64,361

 
57,739

9,295

67,034

Net income including noncontrolling interests
163,847

1,699

165,546

 
178,023

790

178,813

Net income attributable to Bio-Rad
$
163,778

$
1,699

$
165,477

 
$
178,223

$
790

$
179,013

Net income per basic share attributable to Bio-Rad
$
5.79

$
0.06

$
5.85

 
$
6.36

$
0.03

$
6.39

Net income per diluted share attributable to Bio-Rad
$
5.72

$
0.06

$
5.78

 
$
6.26

$
0.03

$
6.29



Following are the amounts in thousands that should have been reported for the Consolidated Statements of Comprehensive Income giving effect to the errors described above:

 
 
Year Ended December 31,
 
 
2012
2011
 
 
 
 
Net unrealized holding gains on AFS investments, net of income tax, understated by $10,090 for the year ended 2012, and overstated by $208 for the year ended 2011.
 
$65,448
$12,663
Income taxes on net unrealized holding gains on AFS investments, understated by $5,874 for the year ended 2012, and overstated by $121 for the year ended 2011.
 
$38,108
$7,373
Reclassification adjustments for net holding (gains) losses on AFS investments included in Net income including noncontrolling interests, net of income tax, understated by $10,090 for the year ended 2012, and overstated by $208 for the year ended 2011.
 
$(5,045)
$104
Income taxes on reclassification adjustments for net holding gains/losses on AFS investments included in Net income including noncontrolling interests, understated by $5,874 for the year ended 2012, and overstated by $121 for the year ended 2011.
 
$(2,937)
$61

us-gaap:ScheduleOfQuantifyingPriorYearMisstatementsCorrectedInCurrentYearFinancialStatementsTextBlock